Sangamo Biosciences reported $1.72B in Market Capitalization for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acceleron Pharma XLRN:US $ 7.62B 606.02M
Alnylam Pharmaceuticals ALNY:US $ 19.93B 3.36B
Amgen AMGN:US $ 140.05B 3.22B
Avrobio Inc AVRO:US $ 371.3M 156.88M
Bayer BAYN:GR 50.48B 2.53B
Biocryst Pharmaceuticals BCRX:US $ 2.81B 1B
Biogen BIIB:US $ 52.13B 9.52B
Biomarin Pharmaceutical BMRN:US $ 15.25B 1.45B
Bluebird Bio BLUE:US $ 2.16B 132.67M
Five Prime Therapeutics FPRX:US $ 1.77B 1.02B
Gilead Sciences GILD:US $ 86.36B 4.99B
GlaxoSmithKline GSK:LN 71.42B 6.62B
Intercept Pharmaceuticals ICPT:US $ 663.03M 98.97M
IONIS PHARMACEUT IONS:US $ 5.62B 710.4M
Johnson & Johnson JNJ:US $ 433825.66M 1140.33M
Karyopharm Therapeutics KPTI:US $ 774.96M 14.69M
Merk MRK:US $ 196918.18M 1780.24M
Novartis NOVN:VX 208.02B 8.76B
Omeros OMER:US $ 924.95M 177.47M
Pfizer PFE:US $ 219205.69M 17108.81M
Regulus Therapeutics RGLS:US $ 60.92M 52.19M
Sangamo Biosciences SGMO:US $ 1.72B 78.47M
Sanofi SAN:FP 111.4B 5.33B
Sarepta Therapeutics SRPT:US $ 6.2B 282.45M
Ultragenyx Pharmaceutical RARE:US $ 6.43B 1.19B
Vertex Pharmaceuticals VRTX:US $ 52.2B 3.42B
Ziopharm Oncology ZIOP:US $ 568.99M 205.75M